The objective of the proposed research is to elucidate the molecular basis of the coordinated developmental expression of the pancreatic serine protease genes. The pancreatic serine protease genes are a family of homologous genes related by common evolution, function, and expression to high levels during pancreatic development. Recombinant DNA techniques have been and will be employed for the isolation of serine protease genes, the analysis of their sequence organization, and the identification of associated potential regulatory elements. We will exploit sequence comparisons between serine protease genes expressed in the pancreas and related serine protease genes expressed in other tissues to delineate sequences that may be involved in tissue-specific expression and to define the pattern of intron movement we have observed for this gene family. The experimental goals include: (1) To determine whether the pancreatic serine protease genes are clustered and whether clustering facilitates genetic mechanisms for their coordinated developmental regulation. (2) To determine whether the expression of one member of the serine protease family, kallikrein, in a large number of rat tissues involves single or multiple structural genes. (3) If a single kallikrein structural gene is expressed in more than one tissue, to investigate whether the regulatory mechanism may be discerned from the sequence organization. (4) To determine the functional importance of the position of intervening sequences and the evolution of changes in the number and position of intervening sequences within th serine protease genes. (5) To develop an in vivo assay to identify gene regulatory regions required for pancreas-specific expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK)
Type
Research Project (R01)
Project #
5R01AM027430-06
Application #
3151747
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1980-12-01
Project End
1988-07-31
Budget Start
1985-08-01
Budget End
1986-07-31
Support Year
6
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
Overall Medical
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Rose, S D; MacDonald, R J (1997) Evolutionary silencing of the human elastase I gene (ELA1). Hum Mol Genet 6:897-903
Kruse, F; Rose, S D; Swift, G H et al. (1995) Cooperation between elements of an organ-specific transcriptional enhancer in animals. Mol Cell Biol 15:4385-94
Rose, S D; Kruse, F; Swift, G H et al. (1994) A single element of the elastase I enhancer is sufficient to direct transcription selectively to the pancreas and gut. Mol Cell Biol 14:2048-57
Swift, G H; Rose, S D; MacDonald, R J (1994) An element of the elastase I enhancer is an overlapping bipartite binding site activated by a heteromeric factor. J Biol Chem 269:12809-15
Kruse, F; Rose, S D; Swift, G H et al. (1993) An endocrine-specific element is an integral component of an exocrine-specific pancreatic enhancer. Genes Dev 7:774-86
Davis, B P; Hammer, R E; Messing, A et al. (1992) Selective expression of trypsin fusion genes in acinar cells of the pancreas and stomach of transgenic mice. J Biol Chem 267:26070-7
Swift, G H; Kruse, F; MacDonald, R J et al. (1989) Differential requirements for cell-specific elastase I enhancer domains in transfected cells and transgenic mice. Genes Dev 3:687-96
MacDonald, R J (1987) Expression of the pancreatic elastase I gene in transgenic mice. Hepatology 7:42S-51S
Hammer, R E; Swift, G H; Ornitz, D M et al. (1987) The rat elastase I regulatory element is an enhancer that directs correct cell specificity and developmental onset of expression in transgenic mice. Mol Cell Biol 7:2956-67
John, M E; John, M C; Boggaram, V et al. (1986) Transcriptional regulation of steroid hydroxylase genes by corticotropin. Proc Natl Acad Sci U S A 83:4715-9

Showing the most recent 10 out of 12 publications